glp-1 cigna limits employer spending on weight loss drugs Glucagon-Like Peptide-1 (GLP-1) Agonists: Decreasing

Contact your GP immediately or call NHS 111 if you experience severe or persistent abdominal pain, particularly if it's sharp, localised, or worsening

Competition in the GLP-1 obesity home delivery injectables market is driven by therapeutic efficacy, dosing convenience, supply reliability, and patient adherence in at-home use settings

Maternal body mass index, gestational weight gain, and the risk of overweight and obesity across childhood: an individual participant data meta-analysis

( Statements Author contributions J-YW and Q-WW wrote the first draft of the manuscript

10.1016/j.ajpc.2024.100679

These findings highlight the importance of targeted therapeutic strategies based on HF phenotypes